Issues of cardiovascular risk management in people with diabetes in the COVID-19 era

Abstract

People with diabetes have a worse prognosis with COVID-19. The disease’s complex pathology may be a challenge for the use of most diabetes medications, due to emerging contraindications that need close monitoring in SARS-CoV-2 infection.

Citation
Ceriello A, Standl E, Catrinoiu D, et al. Diabetes Care 2020;43:1427–32.